Patrick van Berkel
Chief Tech/Sci/R&D Officer en ADC THERAPEUTICS SA .
Fortuna: 3 M $ al 31/03/2024
Perfil
Patrick van Berkel is currently the Chief Scientific Officer at ADC Therapeutics SA. Prior to his current position, he worked at Genmab A as the VP-Antibody, Technology & Chemistry from 2003 to 2012.
Dr. van Berkel holds a doctorate degree from the University of Leiden, which he obtained in 1998.
He also has an undergraduate degree from Radboud University Nijmegen, which he received in 1991.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0.76% | 01/02/2023 | 623 467 ( 0.76% ) | 3 M $ | 31/03/2024 |
Cargos activos de Patrick van Berkel
| Empresas | Cargo | Inicio |
|---|---|---|
| ADC THERAPEUTICS SA | Chief Tech/Sci/R&D Officer | 01/08/2012 |
Antiguos cargos conocidos de Patrick van Berkel.
| Empresas | Cargo | Fin |
|---|---|---|
| GENMAB A/S | Chief Tech/Sci/R&D Officer | 01/01/2012 |
Formación de Patrick van Berkel.
| University of Leiden | Doctorate Degree |
| Radboud University Nijmegen | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENMAB A/S | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
- Bolsa de valores
- Insiders
- Patrick van Berkel
